H. Higuchi

发表

Marked effect of milnacipran combined with olanzapine for a delusional depressive patient

Y. Sugawara, H. Higuchi, Keizo Yoshida, 2005, Neuropsychiatric disease and treatment.

Effectiveness of Milnacipran for the Treatment of Chronic Pain: A Case Series

H. Higuchi, M. Kamata, Hitoshi Takahashi, 2004, Clinical neuropharmacology.

Efficacy of milnacipran in the treatment of chronic pain syndromes

K. Otani, A. Suzuki, H. Higuchi, 2010, International journal of psychiatry in clinical practice.

Milnacipran for the treatment of chronic pain

H. Higuchi, M. Kamata, Hitoshi Takahashi, 2003, Human psychopharmacology.

Different effects of L-type and T-type calcium channel blockers on the hypnotic potency of triazolam and zolpidem in rats

Y. Hishikawa, H. Higuchi, Hitoshi Takahashi, 1999, European Neuropsychopharmacology.

Dopamine releasing response in rat striatum to single and repeated electroconvulsive shock treatment

Y. Hishikawa, H. Higuchi, Keizo Yoshida, 1997, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Effectiveness of switching to quetiapine for neuroleptic-induced amenorrhea.

H. Higuchi, Keizo Yoshida, Tetsuo Shimizu, 2003, The Journal of neuropsychiatry and clinical neurosciences.

Quetiapine treatment of psychotic symptoms and aggressive behavior in patients with dementia with Lewy bodies: A case series

H. Higuchi, Keizo Yoshida, Tetsuo Shimizu, 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Development of parkinsonian symptoms after discontinuation of carbamazepine in patients concurrently treated with risperidone: two case reports.

H. Takahashi, T. Shimizu, H. Higuchi, 2001, Clinical neuropharmacology.

Remarkable effect of milnacipran in the treatment of Japanese major depressive patients

H. Higuchi, Keizo Yoshida, Tetsuo Shimizu, 2002, Human psychopharmacology.

Fluvoxamine augmentation in risperidone‐resistant schizophrenia: an open trial

H. Higuchi, Tetsuo Shimizu, T. Sugita, 2002, Human psychopharmacology.

Favorable effect of milnacipran on depression induced by interferon-alpha.

H. Higuchi, Keizo Yoshida, Tetsuo Shimizu, 2003, The Journal of neuropsychiatry and clinical neurosciences.

Effect of ticlopidine on exercise-induced platelet aggregation and exercise tolerance time in patients with ischemic heart disease.

H. Higuchi, T. Utsunomiya, T. Tokushima, 1999, Journal of cardiovascular pharmacology.

Remarkable effect of selegiline (L-deprenyl), a selective monoamine oxidase type-B inhibitor, in a patient with severe refractory depression: a case report.

Y. Sugawara, H. Higuchi, Keizo Yoshida, 2005, Clinical neuropharmacology.

Gender differences in the clinical effects of fluvoxamine and milnacipran in Japanese major depressive patients.

H. Higuchi, Keizo Yoshida, M. Kamata, 2005, Psychiatry and clinical neurosciences.

Prolactin response to zotepine in schizophrenic patients

K. Otani, H. Higuchi, S. Kaneko, 1993 .

Tardive dystonia and genetic polymorphisms of cytochrome P4502D6 and dopamine D2 and D3 receptors: a preliminary finding.

H. Higuchi, Keizo Yoshida, Hitoshi Takahashi, 2002, American journal of medical genetics.

Single and repeated electroconvulsive shocks activate dopaminergic and 5-hydroxytryptaminergic neurotransmission in the frontal cortex of rats

Y. Hishikawa, H. Higuchi, Keizo Yoshida, 1998, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

High-performance liquid chromatographic determination of fluvoxamine and fluvoxamino acid in human plasma.

K. Otani, H. Higuchi, Keizo Yoshida, 2003, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.

Monoamine oxidase: A gene polymorphism, tryptophan hydroxylase gene polymorphism and antidepressant response to fluvoxamine in Japanese patients with major depressive disorder

K. Itoh, Toshio Suzuki, K. Otani, 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Effect of single intracerebroventricular injection of α-interferon on monoamine concentrations in the rat brain

H. Higuchi, Keizo Yoshida, M. Kamata, 2000, European Neuropsychopharmacology.

Association between serotonin transporter polymorphisms (5-HTTLPR) and the MADRS Dysphoria, Retardation, and Vegetative Subscale scores in the treatment of depression

K. Nishimura, H. Higuchi, Keizo Yoshida, 2017, Neuropsychiatric disease and treatment.

Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms.

C. Nemeroff, K. Itoh, Toshio Suzuki, 2010, The American journal of psychiatry.

Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p.

Naoshi Kaneko, Hiroki Shibata, Takashi Asada, 2005, American journal of human genetics.

Biperiden hydrochlorate ameliorates dystonia of rats produced by microinjection of sigma ligands into the red nucleus

H. Higuchi, Keizo Yoshida, Hitoshi Takahashi, 2000, Pharmacology Biochemistry and Behavior.

Marked Improvement of Tardive Dystonia in a Schizophrenic Patient after Electroconvulsive Therapy

Y. Hishikawa, H. Higuchi, Keizo Yoshida, 1996 .

Marked improvement of tardive dystonia after replacing haloperidol with risperidone in a schizophrenic patient.

Y. Hishikawa, H. Higuchi, K. Yoshida, 1998, Clinical neuropharmacology.

Remarkable effect of milnacipran, a serotonin–noradrenalin reuptake inhibitor (SNRI), on depressive symptoms in patients with Parkinson's disease who have insufficient response to selective serotonin reuptake inhibitors (SSRIs): two case reports

H. Higuchi, Keizo Yoshida, M. Kamata, 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Prediction of Antidepressant Response to Milnacipran by Norepinephrine Transporter Gene Polymorphisms

C. Nemeroff, K. Itoh, Toshio Suzuki, 2004 .

Association between -1438G/A Promoter Polymorphism in the 5-HT2A Receptor Gene and Fluvoxamine Response in Japanese Patients with Major Depressive Disorder

Tetsuo Shimizu, Kunihiko Itoh, Hisashi Higuchi, 2002, Neuropsychobiology.

The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamine

N. Ozaki, K. Itoh, Toshio Suzuki, 2007, Journal of psychopharmacology.

Effects of the CYP 2D6 Genotype and Cigarette Smoking on the Steady‐State Plasma Concentrations of Fluvoxamine and Its Major Metabolite Fluvoxamino Acid in Japanese Depressed Patients

K. Otani, H. Higuchi, Keizo Yoshida, 2003, Therapeutic drug monitoring.

Relationship between clinical effects of fluvoxamine and the steady-state plasma concentrations of fluvoxamine and its major metabolite fluvoxamino acid in Japanese depressed patients

K. Otani, H. Higuchi, Keizo Yoshida, 2003, Psychopharmacology.

Effect of tandospirone on tardive dyskinesia and parkinsonian symptoms

H. Higuchi, T. Sugita, K. Yoshida, 1998, European Psychiatry.

Probable aripiprazole-induced tardive writer's cramp.

H. Higuchi, Keizo Yoshida, Kazuhiro Sato, 2012, The Journal of neuropsychiatry and clinical neurosciences.

No association of the G1287A polymorphism in the norepinephrine transporter gene and susceptibility to major depressive disorder in a Japanese population.

K. Itoh, Toshio Suzuki, H. Higuchi, 2007, Biological & pharmaceutical bulletin.

A variable number of tandem repeats in the serotonin transporter gene does not affect the antidepressant response to fluvoxamine

K. Itoh, H. Takahashi, T. Shimizu, 2002, Psychiatry Research.

The effects of benzodiazepine (triazolam), cyclopyrrolone (zopiclone) and imidazopyridine (zolpidem) hypnotics on the frequency of hippocampal theta activity and sleep structure in rats 1 Presented at the XXth Collegium Internationale Neuro-Psychopharmacologicum Congress, 1996. 1

Y. Hishikawa, T. Shimizu, H. Higuchi, 1999, European Neuropsychopharmacology.

Addition of a dopamine agonist, cabergoline, to a serotonin-noradrenalin reuptake inhibitor, milnacipran as a therapeutic option in the treatment of refractory depression: two case reports.

Takeshi Inoue, H. Higuchi, Keizo Yoshida, 2003, Clinical neuropharmacology.

Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients

K. Itoh, Toshio Suzuki, K. Otani, 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Monoamine Oxidase A Gene Polymorphism, 5-HT2A Receptor Gene Polymorphism and Incidence of Nausea Induced by Fluvoxamine

Tetsuo Shimizu, Kunihiko Itoh, Hisashi Higuchi, 2003, Neuropsychobiology.

Successful treatment of severe antidepressant-induced nausea with a combination of milnacipran and olanzapine.

N. Ozaki, H. Higuchi, K. Yoshida, 2007, Pharmacopsychiatry.

Influence of serotonergic/noradrenergic gene polymorphisms on nausea and sweating induced by milnacipran in the treatment of depression

H. Higuchi, Keizo Yoshida, M. Kamata, 2009, Neuropsychiatric disease and treatment.

Differential clinical effects of fluvoxamine by the effect of age in Japanese female major depressive patients

H. Higuchi, Keizo Yoshida, M. Kamata, 2009, Neuropsychiatric disease and treatment.

Gender differences in the clinical effects of fluvoxamine and milnacipran in Japanese major depressive patients

H. Higuchi, Keizo Yoshida, M. Kamata, 2007 .

Switching to olanzapine after unsuccessful treatment with risperidone during the first episode of schizophrenia: an open-label trial.

J. Ishigooka, H. Higuchi, Keizo Yoshida, 2006, The Journal of clinical psychiatry.

Influence of the tyrosine hydroxylase val81met polymorphism and catechol‐O‐methyltransferase val158met polymorphism on the antidepressant effect of milnacipran

N. Ozaki, K. Itoh, Toshio Suzuki, 2008, Human psychopharmacology.

Genetic polymorphisms in the serotonergic system and symptom clusters of major depressive disorder.

K. Otani, A. Suzuki, H. Higuchi, 2011, Journal of affective disorders.

Ejaculation after defecation without orgasm induced by milnacipran.

H. Higuchi, Keizo Yoshida, Hitoshi Takahashi, 2004, The Journal of neuropsychiatry and clinical neurosciences.

No association between the serotonergic polymorphisms and incidence of nausea induced by fluvoxamine treatment

Kunihiko Ito, Toshio Suzuki, H. Higuchi, 2002, European Neuropsychopharmacology.

Effect of quetiapine in the treatment of panic attacks in patients with schizophrenia: 3 case reports.

H. Higuchi, Keizo Yoshida, Hitoshi Takahashi, 2004, The Journal of neuropsychiatry and clinical neurosciences.

Recurrent paroxysmal episodes characterized by perceptual alteration in three schizophrenic patients on neuroleptic medication

Y. Hishikawa, H. Higuchi, T. Shimizu, 1997, Psychiatry and Clinical Neurosciences.

Bcl1 Polymorphism of the Glucocorticoid Receptor Gene and Treatment Response to Milnacipran and Fluvoxamine in Japanese Patients with Depression

J. Ishigooka, Toshio Suzuki, H. Higuchi, 2014, Neuropsychobiology.

Symptom predictors of response to electroconvulsive therapy in older patients with treatment-resistant depression

H. Higuchi, N. Yamaguchi, Keiichirou Tominaga, 2011, International journal of general medicine.

Predictors of Response to Electroconvulsive Therapy Obtained Using the Three-Factor Structure of the Montgomery and Åsberg Depression Rating Scale for Treatment-Resistant Depressed Patients

H. Higuchi, Mikiko Itaya, N. Yamaguchi, 2010, The journal of ECT.

Milnacipran plasma levels and antidepressant response in Japanese major depressive patients

Y. Hishikawa, H. Higuchi, Keizo Yoshida, 2003, Human psychopharmacology.

Predictors of antidepressant response to fluvoxamine obtained using the three‐factor structures of the Montgomery and Åsberg Depression Rating Scale for major depressive disorders in Japanese patients

K. Otani, H. Higuchi, Keizo Yoshida, 2008, Psychiatry and clinical neurosciences.

A three‐factor model of the MADRS in major depressive disorder

K. Otani, A. Suzuki, H. Higuchi, 2005, Depression and anxiety.

Serum Brain-derived Neurotrophic Factor Levels Following Electroconvulsive Therapy in Treatment-resistant Depressed Patients

H. Higuchi, M. Kamata, Oga Sasaki, 2015 .

Panic attacks in patients with chronic schizophrenia: A complication of long‐term neuroleptic treatment

Y. Hishikawa, H. Higuchi, M. Kamata, 1999, Psychiatry and clinical neurosciences.

association between serotonin transporter polymorphisms (5-hTTlPr) and the MaDrs Dysphoria, retardation, and Vegetative subscale scores in the treatment of depression

K. Nishimura, H. Higuchi, Keizo Yoshida, 2017 .

No predictors of antidepressant patient response to milnacipran were obtained using the three‐factor structures of the Montgomery and Åsberg Depression Rating Scale in Japanese patients with major depressive disorders

K. Otani, H. Higuchi, Keizo Yoshida, 2008, Psychiatry and clinical neurosciences.

Response Rate Obtained Using Milnacipran Depending on the Severity of Depression in the Treatment of Major Depressive Patients

Y. Sugawara, H. Higuchi, Keizo Yoshida, 2006, Clinical neuropharmacology.

Switching to risperidone after unsuccessful treatment of olanzapine in the first-episode schizophrenia: An open trial

J. Ishigooka, H. Higuchi, Keizo Yoshida, 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Augmentation with olanzapine in TCA‐refractory depression with melancholic features: a consecutive case series

J. Ishigooka, H. Higuchi, Keizo Yoshida, 2008, Human psychopharmacology.

Management of phantom limb pain and sensation with milnacipran.

Y. Hishikawa, H. Higuchi, Kazuhiro Sato, 2008, The Journal of neuropsychiatry and clinical neurosciences.

Milnacipran treatment of a terminally ill cancer patient with major depressive disorder

H. Higuchi, Keizo Yoshida, Hitoshi Takahashi, 2004, Human psychopharmacology.